Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
Research context
Voxel S.A. appears in PyInvesting’s Warsaw Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- PLN
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Voxel S.A. is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.
Voxel S.A.'s total revenue rose by 78.3% to $87M since the same quarter in the previous year.
Its net income has increased by 94.2% to $12M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.1% to $3M since the same quarter in the previous year.
Based on the above factors, Voxel S.A. gets an overall score of 3/5.